Daniel E. Benjamin
Company: Cascade Biotechnology Inc.
Job title: Chief Executive Officer
Targeted Delivery Platform of sC3, a Complement Depleting Protein, Using Viral Delivery, Conjugate Guidance, & Localized Application Modalities 3:00 pm
Discover how specific cell types in the retina and kidney can be targeted to express sC3 Conjugate guidance and tissue specific local delivery are being developed to increase efficacy and decrease off target effects Taken together, these technologies allow Cascade to optimize treatment based on the therapeutic targetRead more
day: Day Two